CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BactEradiX aims to develop a novel antimicrobial nanomaterial targeting biofilm DNA to combat chronic infections. By utilizing advanced lipid-based technologies, it seeks to disrupt biofilms and enhance the efficacy of treatments against resistant bacterial strains.
BactEradiX aims to develop the first-in-class advanced antimicrobial nanomaterial to target biofilm Z-DNA and genomic DNA, to eradicate biofilm and resolve chronic/recalcitrant infections.
Infective diseases and antimicrobial resistance are a threat to global health and development.
Biofilm formation is a major cause of treatment failure, infection recurrence and acquired resistance development. WHO has declared antimicrobial resistance one of the top 10 global public health threats facing human…
ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, BOLOGNA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Italy, Perugia
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
UNIVERSITA DEGLI STUDI DI PARMA
Italy, PARMA
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
